Literature DB >> 25241647

Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes.

Ghanshyam Upadhyay1, Sharmila Shankar, Rakesh K Srivastava.   

Abstract

Neurodegenerative diseases are still a challenge for researchers and clinicians due to its complexity. Traditional medicines usually do not provide sufficient protection against these diseases due to drug resistance and relapse. The discovery of the therapeutic potential of stem cells offers new opportunities for the treatment of incurable neurological diseases. Based on their biological properties, stem cells can differentiate into specific tissue type and maintain the cellular tissue/organ homeostasis in physiological and pathological conditions. Recently, it has been demonstrated that somatic cells of patients can be reprogrammed to a pluripotent state from which neural lineage cells can be derived. Potential strategies such as cell replacement therapy and gene transfer to the diseased or injured brain have opened a new line of therapeutic approach for a broad spectrum of human neurological diseases. Thus, stem cell replacement therapy for central and peripheral nervous system disorders aims at repopulating the affected neural tissue with new neurons. However, the limiting factors that have hampered the development of this promising therapeutic approach are the lack of suitable cell types for cell replacement therapy in patients suffering from neurological disorders. In this review, we have discussed the recent advances in stem cell replacement therapy with particular emphasis to neurological disorders.

Entities:  

Mesh:

Year:  2014        PMID: 25241647     DOI: 10.1007/s12035-014-8883-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  151 in total

Review 1.  Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic.

Authors:  Zheng Gang Zhang; Michael Chopp
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

2.  Stem cells: Tailor-made diseased neurons.

Authors:  Michael Sendtner
Journal:  Nature       Date:  2009-01-15       Impact factor: 49.962

3.  Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease.

Authors:  P Brundin; R E Strecker; O Lindvall; O Isacson; O G Nilsson; G Barbin; A Prochiantz; C Forni; A Nieoullon; H Widner
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

4.  Modeling familial Alzheimer's disease with induced pluripotent stem cells.

Authors:  Takuya Yagi; Daisuke Ito; Yohei Okada; Wado Akamatsu; Yoshihiro Nihei; Takahito Yoshizaki; Shinya Yamanaka; Hideyuki Okano; Norihiro Suzuki
Journal:  Hum Mol Genet       Date:  2011-09-07       Impact factor: 6.150

5.  Mesencephalic human neural progenitor cells transplanted into the adult hemiparkinsonian rat striatum lack dopaminergic differentiation but improve motor behavior.

Authors:  Marine Hovakimyan; Stefan Jean-Pierre Haas; Oliver Schmitt; Bernd Gerber; Andreas Wree; Christian Andressen
Journal:  Cells Tissues Organs       Date:  2008-06-19       Impact factor: 2.481

6.  Long-term survival, robust neuronal differentiation, and extensive migration of human forebrain stem/progenitor cells transplanted to the adult rat dorsal root ganglion cavity.

Authors:  Elisabet Akesson; Martin Sandelin; Nadezda Kanaykina; Håkan Aldskogius; Elena N Kozlova
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

7.  Neural stem cells improve memory in an inducible mouse model of neuronal loss.

Authors:  Tritia R Yamasaki; Mathew Blurton-Jones; Debbi A Morrissette; Masashi Kitazawa; Salvatore Oddo; Frank M LaFerla
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

8.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

Review 9.  Brain stimulation for combating Alzheimer's disease.

Authors:  Niels Hansen
Journal:  Front Neurol       Date:  2014-06-02       Impact factor: 4.003

10.  Patient-Specific Induced Pluripotent Stem Cells for SOD1-Associated Amyotrophic Lateral Sclerosis Pathogenesis Studies.

Authors:  I V Chestkov; E A Vasilieva; S N Illarioshkin; M A Lagarkova; S L Kiselev
Journal:  Acta Naturae       Date:  2014-01       Impact factor: 1.845

View more
  8 in total

Review 1.  Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.

Authors:  Ling Liu; Jin-Sha Huang; Chao Han; Guo-Xin Zhang; Xiao-Yun Xu; Yan Shen; Jie Li; Hai-Yang Jiang; Zhi-Cheng Lin; Nian Xiong; Tao Wang
Journal:  Mol Neurobiol       Date:  2015-12-10       Impact factor: 5.590

2.  Extracellular magnetic labeling of biomimetic hydrogel-induced human mesenchymal stem cell spheroids with ferumoxytol for MRI tracking.

Authors:  Sen Yan; Ke Hu; Miao Zhang; Jingyi Sheng; Xueqin Xu; Shijia Tang; Yan Li; Sheng Yang; Guangxiang Si; Yu Mao; Yi Zhang; Feimin Zhang; Ning Gu
Journal:  Bioact Mater       Date:  2022-05-01

Review 3.  Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson's Disease: A Perspective Through Preclinical and Clinical Evidence.

Authors:  Ritam Bandopadhyay; Nainshi Mishra; Ruhi Rana; Gagandeep Kaur; Mohammed M Ghoneim; Sultan Alshehri; Gulam Mustafa; Javed Ahmad; Nabil A Alhakamy; Awanish Mishra
Journal:  Front Pharmacol       Date:  2022-04-07       Impact factor: 5.988

4.  Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors.

Authors:  Jiaofei Zhang; Hui Li; Hao Yang; Jianhua Lin; You Wang; Qianjun Zhang; Wei-Qiang Gao; Huiming Xu
Journal:  J Neuroimmune Pharmacol       Date:  2020-11-09       Impact factor: 4.147

5.  Preparation of Neural Stem Cells and Progenitors: Neuronal Production and Grafting Applications.

Authors:  Lyandysha V Zholudeva; Ying Jin; Liang Qiang; Michael A Lane; Itzhak Fischer
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Multifaceted role of matrix metalloproteinases (MMPs).

Authors:  Divya Singh; Sanjeev K Srivastava; Tapas K Chaudhuri; Ghanshyam Upadhyay
Journal:  Front Mol Biosci       Date:  2015-05-13

Review 7.  The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.

Authors:  Bao Quoc Lam; Sushant K Shrivastava; Anju Shrivastava; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Cell Mol Med       Date:  2020-05-26       Impact factor: 5.310

8.  Transplantation of neural stem cells preconditioned with high‑mobility group box 1 facilitates functional recovery after spinal cord injury in rats.

Authors:  Xin Xue; Liang Zhang; Xiang Yin; Xing-Xing Chen; Zong-Feng Chen; Chen-Xu Wang; Yu Xiang; Ming-Yong Liu; Jian-Hua Zhao
Journal:  Mol Med Rep       Date:  2020-10-06       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.